

JP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management's outlook for recovery and growth in 2025-2027.
You can purchase shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) through any online brokerage.
There are no as such competitors for Fidelity Disruptive Medicine ETF.
There is no analysis for Fidelity Disruptive Medicine ETF to provide a consensus price target.
The stock price for Fidelity Disruptive Medicine ETF (NASDAQ: FMED) is $30.44 last updated October 19, 2026 at 9:28 AM EDT.
There are no upcoming dividends for Fidelity Disruptive Medicine ETF.
Fidelity Disruptive Medicine ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Fidelity Disruptive Medicine ETF.
The fund investing at least 80 percent of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to...